Table 2:

Highest predictive performances of different models in identifying the molecular features of glioblastomas in IDH wild-type lower-grade gliomas in the test set

ModelFeature Selection + ClassifierAUCP Values for Model Comparisons
Model 1 (clinical features)NA0.514 (0.356–0.672)
Model 2 (VASARI features)NA0.648 (0.511–0.784)
Model 3 (VASARI + radiomics features)RFE + SVM0.854 (0.766–0.941)<.001a.023b
Model 4 (clinical + VASARI + radiomics features)RFE + SVM0.863 (0.778–0.947)<.001a.02b.476c
  • Note:—NA indicates not applicable.

  • a Compared with model 1.

  • b Compared with model 2.

  • c Compared with model 3.